Ameriprise
PRME icon

Ameriprise’s Prime Medicine PRME Stock Holding History

Ameriprise’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$173K Sell
49,584
-4,498
-8% -$17.1K ﹤0.01% 3907
2025
Q4 		$188K Sell
54,082
-7,490
-12% -$33.3K ﹤0.01% 3938
2025
Q3 		$341K Buy
+61,572
New +$250K ﹤0.01% 3754
2024
Q4 		– Sell
-28,801
Closed -$111K – 4143
2024
Q3 		$111K Sell
28,801
-1,095
-4% -$5.07K ﹤0.01% 3827
2024
Q2 		$154K Buy
+29,896
New +$181K ﹤0.01% 3724

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Ameriprise's PRME Position: Q1 2026 in Review

Ameriprise reduced its Prime Medicine (PRME) stake by 8.3% in Q1 2026, selling an estimated $17.1K and leaving 49,584 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #3907.

Ameriprise first reported a position in PRME in Q2 2024 and has held it in 5 quarters since. The position peaked at $341K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Ameriprise held 49,584 shares of Prime Medicine worth $173K as of Q1 2026.
  • Ameriprise sold 4,498 Prime Medicine shares in Q1 2026, an estimated $17.1K.
  • Prime Medicine made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3907 holding.
  • Ameriprise first reported a position in Prime Medicine in Q2 2024 and has held it in 5 quarters since.
  • Ameriprise's Prime Medicine position peaked at $341K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.